15-91226303-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001323032.3(SV2B):c.40G>A(p.Ala14Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000354 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001323032.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SV2B | NM_001323032.3 | c.40G>A | p.Ala14Thr | missense_variant | 2/13 | ENST00000394232.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SV2B | ENST00000394232.6 | c.40G>A | p.Ala14Thr | missense_variant | 2/13 | 5 | NM_001323032.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000434 AC: 109AN: 251186Hom.: 0 AF XY: 0.000413 AC XY: 56AN XY: 135750
GnomAD4 exome AF: 0.000358 AC: 524AN: 1461860Hom.: 0 Cov.: 31 AF XY: 0.000352 AC XY: 256AN XY: 727228
GnomAD4 genome AF: 0.000315 AC: 48AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000362 AC XY: 27AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2021 | The c.40G>A (p.A14T) alteration is located in exon 3 (coding exon 1) of the SV2B gene. This alteration results from a G to A substitution at nucleotide position 40, causing the alanine (A) at amino acid position 14 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at